Volume 58, Issue 4, Pages (October 2010)

Slides:



Advertisements
Similar presentations
Volume 53, Issue 3, Pages (March 2008)
Advertisements

Volume 155, Issue 3, Pages (March 1996)
Volume 71, Issue 2, Pages (February 2017)
The PSA Era is not Over for Prostate Cancer
Volume 70, Issue 5, Pages (November 2016)
Volume 50, Issue 1, Pages (July 2006)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 44, Issue 6, Pages (December 2003)
Volume 58, Issue 4, Pages (October 2010)
Volume 57, Issue 5, Pages (May 2010)
Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer  Marisa Warmuth,
Volume 74, Issue 4, Pages (October 2018)
Prostate Cancer: Highlights from 2006
Volume 69, Issue 2, Pages (February 2016)
Volume 61, Issue 5, Pages (May 2012)
Combination of Alfuzosin and Sildenafil is Superior to Monotherapy in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction  Steven A. Kaplan,
Volume 60, Issue 5, Pages (November 2011)
Volume 53, Issue 5, Pages (May 2008)
Volume 64, Issue 4, Pages (October 2013)
Control of Prostate Cancer by Transrectal HIFU in 227 Patients
Volume 65, Issue 5, Pages (May 2014)
Volume 70, Issue 4, Pages (October 2016)
Volume 70, Issue 2, Pages (August 2016)
Volume 71, Issue 2, Pages (February 2017)
Prostate Cancer Epidemic in Sight?
Volume 52, Issue 4, Pages (October 2007)
Nomograms for Bladder Cancer
Volume 50, Issue 4, Pages (October 2006)
Volume 67, Issue 2, Pages (February 2015)
Volume 54, Issue 4, Pages (October 2008)
Volume 71, Issue 1, Pages 1-3 (January 2017)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Volume 53, Issue 4, Pages (April 2008)
Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?
Volume 70, Issue 3, Pages (September 2016)
Prostate Cancer Detection: A View of the Future
Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance  Adam B. Weiner, Ruth Etzioni, Scott E. Eggener 
Volume 70, Issue 4, Pages (October 2016)
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 64, Issue 4, Pages (October 2013)
Volume 67, Issue 6, Pages (June 2015)
Volume 71, Issue 5, Pages (May 2017)
Volume 70, Issue 5, Pages (November 2016)
Volume 64, Issue 6, Pages (December 2013)
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Volume 53, Issue 2, Pages (February 2008)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 53, Issue 6, Pages (June 2008)
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
The Inside-Out Transobturator Male Sling for the Surgical Treatment of Stress Urinary Incontinence After Radical Prostatectomy: Midterm Results of a Single-Center.
Volume 68, Issue 4, Pages (October 2015)
Volume 70, Issue 2, Pages (August 2016)
Volume 50, Issue 5, Pages (November 2006)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 51, Issue 2, Pages (February 2007)
Testicular Cancer Variations in Time and Space in Europe
Volume 53, Issue 1, Pages (January 2008)
The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.
Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?
Long-Term Hormonal Therapy: Who Would Benefit?
Christian Stief  European Urology Supplements 
Volume 54, Issue 1, Pages (July 2008)
Volume 53, Issue 6, Pages (June 2008)
Management of Prostate Cancer: Global Strategies
Volume 53, Issue 2, Pages (February 2008)
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 58, Issue 4, Pages 567-573 (October 2010) Salvage Radiotherapy After High-Intensity Focussed Ultrasound for Recurrent Localised Prostate Cancer  Julien Riviere, Jean-Christophe Bernhard, Grégoire Robert, Hervé Wallerand, Edouard Deti, Sylvie Maurice-Tison, Jean-Michel Ardiet, Jean-Philippe Maire, Pierre Richaud, Jean-Marie Ferriere, Philippe Ballanger, Albert Gelet, Gilles Pasticier  European Urology  Volume 58, Issue 4, Pages 567-573 (October 2010) DOI: 10.1016/j.eururo.2010.06.003 Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 1 Progression-free survival for 83 patients treated by radiotherapy alone. European Urology 2010 58, 567-573DOI: (10.1016/j.eururo.2010.06.003) Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 2 Progression-free survival according to risk group following salvage radiotherapy. LR=low risk; IR=intermediate risk; HR=high risk. European Urology 2010 58, 567-573DOI: (10.1016/j.eururo.2010.06.003) Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 3 Progression-free survival according to prostate-specific antigen (PSA) nadir following salvage radiotherapy. European Urology 2010 58, 567-573DOI: (10.1016/j.eururo.2010.06.003) Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 4 Urinary incontinence before and after salvage radiotherapy (SRT) for patients failing high-intensity ultrasound. European Urology 2010 58, 567-573DOI: (10.1016/j.eururo.2010.06.003) Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 5 International Index of Erectile Dysfunction–5 scores in 79 patients prior to treatment with high-intensity focussed ultrasound (HIFU), following HIFU failure and immediately prior to salvage radiotherapy (SRT) for HIFU failure, and at 1 yr post-SRT. ED=erectile dysfunction. European Urology 2010 58, 567-573DOI: (10.1016/j.eururo.2010.06.003) Copyright © 2010 European Association of Urology Terms and Conditions